TY - JOUR
T1 - Reappraisal of the provisional entity primary cutaneous CD4+ small/medium pleomorphic T-cell lymphoma
T2 - A series of 10 adult and pediatric patients and review of the literature
AU - Baum, Christian L.
AU - Link, Brian K.
AU - Neppalli, Vishala T.
AU - Swick, Brian L.
AU - Liu, Vincent
PY - 2011/10
Y1 - 2011/10
N2 - Background: Primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoma (PCSM-TCL) was defined as a provisional entity in the 2005 World Health Organization - European Organization for Research and Treatment of Cancer classification of cutaneous lymphomas. A limited number of reports describe a generally indolent but heterogeneous condition. Objective: We reviewed the concept of PCSM-TCL when applied to our experience and to the published literature. Methods: We conducted a retrospective chart review and a PubMed search to identify all reported cases of PCSM-TCL from 2005 to 2010. Results: Ten patients, including 4 of the youngest described, were identified in our institution, and their clinical and pathologic features were analyzed. All had a benign clinical course. Ten reports of patients with PCSM-TCL were reviewed and commonalities were found within an otherwise variable spectrum of clinical presentation, pathology, and biologic behavior. Limitations: This study was retrospective, follow-up was short term in some cases, and data were limited in a number of published reports. Conclusions: Our experience of 10 cases that met the diagnostic criteria of the provisional entity PCSM-TCL highlights its occurrence in children and further supports characterization of this condition as a clonal T-cell lymphoproliferative disorder with indolent behavior.
AB - Background: Primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoma (PCSM-TCL) was defined as a provisional entity in the 2005 World Health Organization - European Organization for Research and Treatment of Cancer classification of cutaneous lymphomas. A limited number of reports describe a generally indolent but heterogeneous condition. Objective: We reviewed the concept of PCSM-TCL when applied to our experience and to the published literature. Methods: We conducted a retrospective chart review and a PubMed search to identify all reported cases of PCSM-TCL from 2005 to 2010. Results: Ten patients, including 4 of the youngest described, were identified in our institution, and their clinical and pathologic features were analyzed. All had a benign clinical course. Ten reports of patients with PCSM-TCL were reviewed and commonalities were found within an otherwise variable spectrum of clinical presentation, pathology, and biologic behavior. Limitations: This study was retrospective, follow-up was short term in some cases, and data were limited in a number of published reports. Conclusions: Our experience of 10 cases that met the diagnostic criteria of the provisional entity PCSM-TCL highlights its occurrence in children and further supports characterization of this condition as a clonal T-cell lymphoproliferative disorder with indolent behavior.
KW - cutaneous T-cell lymphoma
KW - cutaneous lymphoma
KW - cutaneous nodular proliferation of pleomorphic T lymphocytes of undetermined significance
KW - indolent
KW - lymphoproliferative
KW - pediatrics
KW - peripheral T-cell lymphoma
KW - pseudolymphoma
UR - http://www.scopus.com/inward/record.url?scp=80052799525&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=80052799525&partnerID=8YFLogxK
U2 - 10.1016/j.jaad.2010.07.028
DO - 10.1016/j.jaad.2010.07.028
M3 - Article
C2 - 21641676
AN - SCOPUS:80052799525
SN - 0190-9622
VL - 65
SP - 739
EP - 748
JO - Journal of the American Academy of Dermatology
JF - Journal of the American Academy of Dermatology
IS - 4
ER -